Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pannuti

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Pharmacokinetics of PTT-119 in manF Pannuti, G Coppi, F Borella, et al.
Cancer Treatment Reports|October 1, 1980
High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trialF Pannuti, G Lelli, M Casadio, et al.
Anticancer Research|May 1, 1992
Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancerA Martoni, A Cricca, M Guaraldi, et al.
The International Journal of Biological Markers|July 1, 1988
CA 15.3 and CEA plasma level monitoring in patients with breast cancerA Martoni, L Ercolino, B Bellanova, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1989
A phase III study on intermittent versus weekly cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, A Farris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patientsC M Camaggi, E Strocchi, R Comparsi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancerC M Camaggi, E Strocchi, B Costanti, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over studyC M Camaggi, E Strocchi, P Carisi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
High-dose epirubicin for untreated patients with advanced tumours: a phase I studyA Martoni, B Melotti, M Guaraldi, et al.
Tumori|June 11, 1999
A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study GroupF Pannuti, G Robustelli della Cuna, V Ventaffrida, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Pharmacokinetics of PTT-119 in manF Pannuti, G Coppi, F Borella, et al.
Cancer Treatment Reports|October 1, 1980
High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trialF Pannuti, G Lelli, M Casadio, et al.
Anticancer Research|May 1, 1992
Weekly regimen of 5-FU vs 5-FU + intermediate dose folinic acid in the treatment of advanced colorectal cancerA Martoni, A Cricca, M Guaraldi, et al.
The International Journal of Biological Markers|July 1, 1988
CA 15.3 and CEA plasma level monitoring in patients with breast cancerA Martoni, L Ercolino, B Bellanova, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1989
A phase III study on intermittent versus weekly cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, A Farris, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patientsC M Camaggi, E Strocchi, R Comparsi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancerC M Camaggi, E Strocchi, B Costanti, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over studyC M Camaggi, E Strocchi, P Carisi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
High-dose epirubicin for untreated patients with advanced tumours: a phase I studyA Martoni, B Melotti, M Guaraldi, et al.
Tumori|June 11, 1999
A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study GroupF Pannuti, G Robustelli della Cuna, V Ventaffrida, et al.
Pageof 10